Ghana launches public-private partnership to control malaria

Ghana's Ministry of Health recently launched the Nationwide Mosquito Control Programme (NAMCOP) in conjunction with the waste management company Zoomlion Ghana Limited, the Ghanaian Chronicle/allAfrica.com reports (Akweetey, Ghanaian Chronicle/allAfrica.com, 6/19).

George Sipa Yankey, Ghana's health minister, said the government is committed to eliminating malaria and that the initiative will be part of a sustained effort so that Ghana can be the first country in West African to eliminate the disease. He said the government also plans to help the region by transferring local malaria elimination skills to other countries in West Africa.

Yankey said NAMCOP will include indoor and outdoor residual spraying of households and boarding schools, intermittent preventive treatment for pregnant women and the distribution of insecticide-treated nets (Amankwah, Public Agenda/allAfrica.com, 6/19). Alhaji Habib Mohammed Ziblim, the coordinator of Zoomlion in charge of NAMCOP, said the company would aim to control the mosquito population to prevent mosquito-transmitted diseases such as malaria, as well as filariasis, yellow fever and viral hemorrhagic fever.

Ziblim said Zoomlion would clean drains and de-silt them to prevent stagnant water – a breeding ground for mosquitoes – from accumulating. In addition, the company will clear bushes, domestic garbage and spray existing stagnant water. He said for the project Zoomlion had acquired 500,000 spraying machines, 300 motorbikes, 30 trucks, insecticides and other related equipment (Ghanaian Chronicle/allAfrica.com, 6/19).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
A promising new strategy for malaria drug development